Quick Answer
Accustem Sciences Inc. reported Diluted EPS of $0.13 per share (loss) for fiscal year 2024.
Accustem Sciences Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$0.13 | +27.8% |
| 2023 | -$0.18 | +47.1% |
| 2022 | -$0.34 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.02 | +33.3% | +0.0% |
| June 30, 2025 | -$0.02 | +0.0% | +33.3% |
| March 31, 2025 | -$0.03 | +40.0% | +0.0% |
| September 30, 2024 | -$0.03 | +40.0% | -50.0% |
| June 30, 2024 | -$0.02 | +33.3% | +60.0% |
| March 31, 2024 | -$0.05 | +28.6% | +0.0% |
| September 30, 2023 | -$0.05 | +37.5% | -66.7% |
| June 30, 2023 | -$0.03 | +70.0% | +57.1% |
- Accustem Sciences Inc. showed an increase of +27.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2024 period, Accustem Sciences Inc.’s diluted eps has grown by 61.8% (from $0.34 per share (loss) to $0.13 per share (loss)).
- The most recent figure is from Accustem Sciences Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: